These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 21187868)

  • 1. Predictors of large volume paracantesis induced circulatory dysfunction in patients with massive hepatic ascites.
    Nasr G; Hassan A; Ahmed S; Serwah A
    J Cardiovasc Dis Res; 2010 Jul; 1(3):136-44. PubMed ID: 21187868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of paracentesis flow rate in patients with liver cirrhosis on the development of paracentesis induced circulatory dysfunction.
    Elsabaawy MM; Abdelhamid SR; Alsebaey A; Abdelsamee E; Obada MA; Salman TA; Rewisha E
    Clin Mol Hepatol; 2015 Dec; 21(4):365-71. PubMed ID: 26770925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large volume abdominal paracentesis effect on some humoral factors and cardiac performance in patients with liver cirrhosis and tense ascities.
    El-Ashry N; El-Damarawy M; Salem M; Mogawer S
    J Egypt Soc Parasitol; 2007 Aug; 37(2):571-84. PubMed ID: 17985589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites.
    Sola-Vera J; Miñana J; Ricart E; Planella M; González B; Torras X; Rodríguez J; Such J; Pascual S; Soriano G; Pérez-Mateo M; Guarner C
    Hepatology; 2003 May; 37(5):1147-53. PubMed ID: 12717396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of midodrine and albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients: a randomized pilot study.
    Hamdy H; ElBaz AA; Hassan A; Hassanin O
    J Clin Gastroenterol; 2014 Feb; 48(2):184-8. PubMed ID: 23842215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of cirrhotic tense ascites with Dextran-40 versus albumin associated with large volume paracentesis: a randomized controlled trial.
    García-Compean D; Blanc P; Larrey D; Daures JP; Hirtz J; Mendoza E; Maldonado H; Michel H
    Ann Hepatol; 2002; 1(1):29-35. PubMed ID: 15114293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paracentesis with Dextran 70 vs. paracentesis with albumin in cirrhosis with tense ascites. Results of a randomized study.
    Fassio E; Terg R; Landeira G; Abecasis R; Salemne M; Podesta A; Rodriguez P; Levi D; Kravetz D
    J Hepatol; 1992 Mar; 14(2-3):310-6. PubMed ID: 1380024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: a cross-over study.
    Sersté T; Francoz C; Durand F; Rautou PE; Melot C; Valla D; Moreau R; Lebrec D
    J Hepatol; 2011 Oct; 55(4):794-9. PubMed ID: 21354230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paracentesis-Induced Circulatory Dysfunction With Modest-Volume Paracentesis Is Partly Ameliorated by Albumin Infusion in Acute-on-Chronic Liver Failure.
    Arora V; Vijayaraghavan R; Maiwall R; Sahney A; Thomas SS; Ali R; Jain P; Kumar G; Sarin SK
    Hepatology; 2020 Sep; 72(3):1043-1055. PubMed ID: 31849085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology and Prevention of Paracentesis-induced Circulatory Dysfunction: A Concise Review.
    Kulkarni AV; Kumar P; Sharma M; Sowmya TR; Talukdar R; Rao PN; Reddy DN
    J Clin Transl Hepatol; 2020 Mar; 8(1):42-48. PubMed ID: 32274344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
    Tan HK; James PD; Wong F
    Dig Dis Sci; 2016 Oct; 61(10):3084-3092. PubMed ID: 27048451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy and safety of large volume paracentesis in cirrhotic patients with spontaneous bacterial peritonitis: a randomized prospective study].
    Choi CH; Han KH; Kim DY; Cho JH; Cheong JY; Song KH; Chon CY; Moon YM
    Taehan Kan Hakhoe Chi; 2002 Mar; 8(1):52-60. PubMed ID: 12499817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low dose albumin for the prevention of renal impairment following large volume paracentesis in cirrhosis.
    Hussain W; Khalid AB; Usmani T; Ghufran A; Shah H
    Pak J Med Sci; 2015; 31(3):592-6. PubMed ID: 26150850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis.
    Bucsics T; Hoffman S; Grünberger J; Schoder M; Matzek W; Stadlmann A; Mandorfer M; Schwabl P; Ferlitsch A; Peck-Radosavljevic M; Trauner M; Karner J; Karnel F; Reiberger T
    Liver Int; 2018 Jun; 38(6):1036-1044. PubMed ID: 29091351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study.
    Planas R; Ginès P; Arroyo V; Llach J; Panés J; Vargas V; Salmerón JM; Ginès A; Toledo C; Rimola A
    Gastroenterology; 1990 Dec; 99(6):1736-44. PubMed ID: 1699835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large volume paracentesis and intravenous dextran to treat tense ascites.
    Acharya SK; Balwinder S; Padhee AK; Nijhawan S; Tandon BN
    J Clin Gastroenterol; 1992 Jan; 14(1):31-5. PubMed ID: 1372924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.
    Appenrodt B; Wolf A; Grünhage F; Trebicka J; Schepke M; Rabe C; Lammert F; Sauerbruch T; Heller J
    Liver Int; 2008 Aug; 28(7):1019-25. PubMed ID: 18410283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis.
    Ginès A; Fernández-Esparrach G; Monescillo A; Vila C; Domènech E; Abecasis R; Angeli P; Ruiz-Del-Arbol L; Planas R; Solà R; Ginès P; Terg R; Inglada L; Vaqué P; Salerno F; Vargas V; Clemente G; Quer JC; Jiménez W; Arroyo V; Rodés J
    Gastroenterology; 1996 Oct; 111(4):1002-10. PubMed ID: 8831595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albumin infusion fails to restore circulatory function following paracentesis of tense ascites as assessed by beat-to-beat haemodynamic measurements.
    Schneditz D; Bachler I; Stadlbauer V; Stauber RE
    Int J Clin Pract; 2008 Dec; 62(12):1851-7. PubMed ID: 17927765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites.
    Pozzi M; Carugo S; Boari G; Pecci V; de Ceglia S; Maggiolini S; Bolla GB; Roffi L; Failla M; Grassi G; Giannattasio C; Mancia G
    Hepatology; 1997 Nov; 26(5):1131-7. PubMed ID: 9362352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.